2020 Insights into the Indian Cough, Cold and Allergy (Hay Fever) Remedies Industry - Pinpoint Growth Sectors - ResearchAndMarkets.com

The "Cough, Cold and Allergy (Hay Fever) Remedies in India" report has been added to ResearchAndMarkets.com's offering.

COVID-19 has made consumers more conscious of symptoms such as throat itches, sore throats, and coughs, as well as colds, and encouraged them to take a more proactive approach to the treatment of such symptoms. Moreover, this strengthened consumers' desire to stock up on medication for coughs and colds, especially under the strict lockdown conditions prevailing during the period from March to June.

The Cough, Cold and Allergy (Hay Fever) Remedies in India report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2015-2019, allowing you to identify the sectors driving growth. Forecasts to 2024 illustrate how the market is set to change.

Product coverage: Antihistamines/Allergy Remedies (Systemic), Combination Products - Cough, Cold and Allergy (Hay Fever) Remedies, Cough Remedies, Decongestants, Medicated Confectionery, Paediatric Cough, Cold and Allergy Remedies, Pharyngeal Preparations.

Data coverage: Market sizes (historic and forecasts), company shares, brand shares and distribution data.

Why buy this report?

• Get a detailed picture of the Cough, Cold and Allergy (Hay Fever) Remedies market;
• Pinpoint growth sectors and identify factors driving change;
• Understand the competitive environment, the market's major players and leading brands;
• Use five-year forecasts to assess how the market is predicted to develop.

Key Topics Covered:

1. KEY DATA FINDINGS

2. 2020 IMPACT

• Fast relief products favoured over traditional formats
• Home seclusion contributes to dip in growth
• Procter & Gamble retains lead as lockdown affects supply chain

3. RECOVERY AND OPPORTUNITIES

• Ayurvedic tradition provides potential for revival of natural trend
• Pollution set to generate demand for cough, cold and allergy (hay fever) remedies
• Potential for further expansion of online pharmacies

4. CATEGORY DATA

• Table 1 Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: Value 2015-2020
• Table 2 Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: % Value Growth 2015-2020
• Table 3 NBO Company Shares of Cough, Cold and Allergy (Hay Fever) Remedies: % Value 2016-2020
• Table 4 LBN Brand Shares of Cough, Cold and Allergy (Hay Fever) Remedies: % Value 2017-2020
• Table 5 Forecast Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: Value 2020-2025
• Table 6 Forecast Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: % Value Growth 2020-2025

5. EXECUTIVE SUMMARY

• COVID-19 impact on consumer health
• COVID-19 country impact
• Company response
• Retailing shift
• What next for consumer health?

6. MARKET INDICATORS

• Table 7 Consumer Expenditure on Health Goods and Medical Services: Value 2015-2020
• Table 8 Life Expectancy at Birth 2015-2020

7. MARKET DATA

• Table 9 Sales of Consumer Health by Category: Value 2015-2020
• Table 10 Sales of Consumer Health by Category: % Value Growth 2015-2020
• Table 11 NBO Company Shares of Consumer Health: % Value 2016-2020
• Table 12 LBN Brand Shares of Consumer Health: % Value 2017-2020
• Table 13 Distribution of Consumer Health by Format: % Value 2015-2020
• Table 14 Distribution of Consumer Health by Format and Category: % Value 2020
• Table 15 Forecast Sales of Consumer Health by Category: Value 2020-2025
• Table 16 Forecast Sales of Consumer Health by Category: % Value Growth 2020-2025

8. APPENDIX

• OTC registration and classification
• Vitamins and dietary supplements registration and classification
• Self-medication/self-care and preventive medicine

9. GLOBAL MACROECONOMIC ENVIRONMENT

10. GLOBAL INDUSTRY ENVIRONMENT

11. DISCLAIMER

12. DEFINITIONS

13. SOURCES

For more information about this report visit https://www.researchandmarkets.com/r/eutn9n

View source version on businesswire.com: https://www.businesswire.com/news/home/20210115005478/en/